MARSHALL WACE, LLP - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$208,094
-62.0%
462,430
-25.7%
0.00%
-100.0%
Q3 2022$547,000
-41.4%
622,378
-23.3%
0.00%
-50.0%
Q2 2022$933,000
-66.7%
811,435
-49.3%
0.00%
-60.0%
Q1 2022$2,801,000
-6.0%
1,600,343
+73.9%
0.01%
-16.7%
Q4 2021$2,981,000920,2410.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders